Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 1
Submit an article Journal homepage
302
Views
34
CrossRef citations to date
0
Altmetric
Research Article

FLT3 and its Role in the Pathogenesis of Acute Myeloid Leukaemia

John T. Reilly Molecular Haematology Unit, Division of Molecular and Genetic Medicine, M floor, Royal Hallamshire Hospital, Sheffield S10 2JF, UK
Pages 1-7 | Published online: 01 Jul 2009

  • Lyman, S.D., James, L., Vanden Bos, T., de Vries, P., Brasel, K., Gliniak, B., Hollingsworth, L.T., Picha, K.S., McKenna, H.J., Splett, R.R., et al. (1993) "Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells'', Cell 17, 1157-1167.
  • Hannum, c., Culpepper, J., Campbell, D., McClanahan, T., Zurawski, S., Bazan, J.F., Kastelein. R., Hudak, S., Wagner, J., Mattson, J., et al. (1994) ``Ligand for FLT3/FLK2 receptor tyrosine kinase regulating growth of haematopoietic stem cells and is encoded by variant RNAs'', Nature 368, 643-648.
  • Lyman, S.d., James, L., Johnson, L., Brasel, K., de Vries, P., Esocobar, S.S., Downey, H., Splett, R.R., Beckmann, M.P., and McKenna, H.J. (1994) ``Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells'', Blood 83, 2795-2801.
  • Jacobsen, S.E., Okkenhaug, C., Myklebust, J., Veiby, O.P. and Lyman, S.D. (1995) ``The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors'', Journal of Experimental Medicine 181, 1357-1363.
  • Veiby, O.P., Lyman, S.D. and Jacobsen, S.E. (1996) ``Combined signalling through interleukin-7 receptors and flt3 but not c-kit potently and selectively and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells''. Blood 88, 1256-1265.
  • Hunte, B. E., Hudak, S., Campbell, D., Xu, Y. and Rennick, D. (1996) ``Flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors'', Journal of Immunology 156, 489-496.
  • Hirayama, F., Lyman, S.D., Clark, S.C. and Ogawa, M. (1995) ``The Flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors'', Blood 85, 1762-1768.
  • Broxmeyer, H.E., Lu, L., cooper, s., Ruggieri, L., Li, Z.H. and Lyman, S.D. (1995) ``Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells'', Experimental Hematology 23, 1121-1129.
  • McKenna, H.J., de Vries, P., Brasel, K., Lyman, S.D. and Williams, D.E. (1995) ``Effect of Flt3 ligand on the ex vivo expansion of human CD34 + hematopoietic progenitor cells'', Blood 86, 3413-3420.
  • Steptoe, R.J., Fu, F., Li, W., Drakes, M.L., Lu, L., Demetris, A.J., Qian, S., McKenna, H.J. and Thompson, A.W. (1997) ``Augmentation of dendritic cells in murine organ donors by flt3 ligand alters the balance between transplant tolerance and immunity'', Journal of Immunology 159, 5483-5491.
  • Shaw, S.G., Maung, A.A., Steptoe, R.J. and Thomson, A.W. (1998) ``Expansion of functional NK cells in multiple tissue compartments of mice treated with flt3 ligand: implications for anti-cancer and anti-viral therapy'', Journal of Immunology 161, 2817-2824.
  • Rosnet, O., Marchetto, s., de Lapeyriere, O. and Birnbaum, D. (1991) ``Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF-IR family'', Oncogene 6, 1641-1650.
  • Matthews, W., Jordan, C., Gavin, M., Jenkins, N., Copeland, N. and Lemischka, I.(1991) ``A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit'', Proceedings of the National Academy of Sciences of the United States of America 88, 9026-9039.
  • Ullrich, A. and Schlessinger, J. (1990) ``Signal transduction by receptors with tyrosine activity'', Cell 61, 203-212.
  • Abu-Duhier, P.M., Goodeve, A.C., Wilson, G.A., Care, R.S., Peake, I.R. and Reilly, J.T. (2001) "Genomic structure of human FLT3: implications for mutational analysis", British Journal of Haematology 113, 1076-1077.
  • Zhang, S., Mantel, C. and Broxmeyer, H.E. (1999) "Flt3 signalling involves lyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and She in Baf3/Flt3 cells", Journal of Leucocyte Biology 65, 372 380.
  • Lavagna-Sevenier, C., Marchertto, S., Birnbaum, D. and Rosnet, O. (1998) "The CBL-related protein CBLB participates in FLT3 and interleukin 7 receptor signal transduction in pro-B cells", Journal of Biological Chemistry 273, 14962-14967.
  • Zhang, S. and Broxmeyer, H.E. (2000) "Flt3 ligand induces tyrosine phosphorylation of Gab1 and Gab2 and their association with Shp-2, Grb2, and P13 kinase", Biochemical and Biophysical Research Communications 277, 195-199.
  • Braun, S.E., Aronica, S.M., Ge, Y., Takahira, H., Elienne-Julan, M., Lu, L., Minden, M.D. and Lyman, S.D. (1997) "Retroviral mediated gene transfer of FLT3 ligand enhances proliferation and MAP kinase activity of AML5 cells", Experimental Haematology 25, 51-56.
  • Rottapel, R., Turck, C.W., Casteran, N., Liu, X., Birnbaum, D., Pawson, T. and Dubreuil, P. (1994) "Substrate specificities and identification of a putative binding site for PT3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase", Oncogene 9, 1755-1765.
  • Carow, C.E., Levenstein, M., Kaufmann, S.H., et al. (1996) "Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias", Blood 87, 1089-1096.
  • Drexler, H.G. (1996) "Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells", Leukemia 10, 588-599.
  • Zeigler, F.C., Bennett, B.D., Jordan, C.T., Spencer, S.D., Baumhueter, S., Carroll, K.J., Hooley, J., Bauer, K. and Matthews, W. (1994) "Cellular and molecular characteristics of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells", Blood 84, 2422 2430.
  • Small, D., Levenstein, M., Kim, E., Carow, C., Amin, S., Rockwell, P., Witte, L., Burrow, C., Ratajczak, M.Z., Gewirtz, A.M., et al. (1994) "STK-1, the human homolog of Flk-2/Flt-3,is selectively expressed in CD34 + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells", Proceedings of the National Academy of Sciences of the United States of America 91, 459-463.
  • Stacchini, A., Hubini, L., Severino, A., Sanavio, F., Aligetta, M. and Piacibello, W. (1996) "Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukaemia blasts", Leukaemia 10, 1584-1591.
  • Dehmel, U., Zaborski, M., Meierhoff, G., Rosnet, O., Birnhaum, D., Ludwig, W.D., Quentmeier, H. and Drexler, H.G. (1996) "Effects of FLT3 ligand on human leukaemia cells. I. Proliferative response of myeloid leukaemia cells", Leukemia 10, 261-270.
  • Lisovsky, M., Estrov, Z., Zhang, X., Consoli, U., Sanchez-Williams, G., Snell, V., Munker, R., Goodacre, A., Savchenko, V. and Andreeff, M. (1996) ``Flt3 tigand stimulates proliferation and inhibits apoptosis of acute myeloid leukaemia cells: regulation of Bcl-2 and Bax", Blood 88, 3987-3997.
  • Hawley, T.S., Fong, A.Z., Griesser, H., Lyman, S.D. and Hawley, R.G. (1998) "Leukemic predisposition of mice transplanted with gene-modified hematopoielic precursors expressing flt3 ligand", Blood 92, 2003-2011.
  • Nakao, M., Yokota, S., Iwai, T., Kaneko, H., Horiike, S., Kashima, K., Sonoda, Y., Fujimoto, T. and Misawa, S. (1996) "Internal tandem duplication of the flt3 gene found in acute myeloid leukemia", Leukemia 10, 1911-1918.
  • Xu, F., Yang, HW., Hanada, R., Hongo, T., Ohnishi, H., Kobayashi, M., Bessho, F., Yanagisawa, M. and Hayashi, Y. (1999) ``Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children", British Journal of Haematology 105, 155-162.
  • Frohling, S., Breitruck, J., Schlenk, R., Hreitmeier, S., Tobis, K., Dohner, H. and Dohner, K. (2001) "FLT3 internal tandem duplications and survival in adult acute myeloid leukaemia: analysis of 188 intensively treated patients", Blood 89, 717a.
  • Abu-Duhier, F.M., Goodeve, A.C., Wilson, G.A., Gari, M.A., Peake, I.R., Rees, D.C., Vandenberghe, E.A., Winship, P.R. and Reilly, J.T. (2000) "FLT3 internal tandem duplication mutations inacute myeloid leukaemia define a high risk group". British Journal of Hematology III, 190-195.
  • Kottaridis, P.D., Gale, R.E., Frew, M.E., Harrison, G., Langabeer, S.E., Belton, A.A., Walker, H., Wheatley, K., Bowen, D.T., Burnet, A.K., Goldstone, A.H. and Linch, D.C. (2001 ) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukaemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials", Blood 98, 1752-1759.
  • Whitman, S.P., Archer, K.J., Feng, L., Baldus, C., Becknell, B., Carlson, B.D., Carroll, A.J., Mrozek, K., Vardiman, J.W., George, S.L., Kolitz, J.E., Larson, R.A., Bloomfield, C.D. and Caligiuri, M.A. (2001) "Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukaemia with normal cytogeneties and the internal tandem duplication of FLT3: a cancer and leukaemia group B study", Cancer Research 61, 7233-7239.
  • Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schakel, U., Platzbecker, U., Wermke, M., Bornhauser, M., Ritter, M., Neubauer, A., Ehninger, G. and Illmer, T. (2002) "Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukaemia: association with FAB subtypes and identification of subgroups with poor prognosis", Blood 99, 4326-4335.
  • Yokota, S., Kiyoi, H., Nakao, M., Iwai, T., Misawa, S., Okuda, T., Sonoda, Y., Abe, T., Kahsima, K., Matsuo, Y. and Naoe, T. (1997) "Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukaemia and myelodysplastic syndrome among various haematological malignancies. A study on a large series of patients and cell lines", Leukaemia 11, 1605-1609.
  • Iwai, T., Yokota, S., Nakao, M., Okamoto, T., Taniwaki, M., Onodera, N., Watanabe, A., Kikula, A., Tanaka, A., Asami, K., Sekine, I., Mugishima, H., Nishimura, Y., Koizumi, S., Horikoshi, Y., Mimaya, J., Ohta, S., Nishikawa, K., Iwai, A., Shimokawa, T., Nakayama, M., Kawakami, K., Gushiken, T., Hyakuna, N., Katano, N., Tsurusawa, M., and Fujimoto, T. (1999) "Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukaemia", Leukaemia 13, 38-43.
  • Stirewalt, D.L., Kopecky, K.J., Meshinchi, S., Appelbaum, FR., Slovak, M.L., Willman, C.L. and Radich, J.P. (2001) "FLT3, RAS and TP53 mutations in elderly patients with acute myeloid leukaemia", Blood 97, 3589-3595.
  • Chi, H.-S., Yang, S.-E., Choi, S.J., Park, C.J., Seo, E.J. and Lee, K.H. (2000) "Internal tandem duplication of the FLT3 gene in acute leukaemia: clinical and prognostic implications in acute myeloid leukaemia", Blood 96, 104a.
  • Nakao, M., Janssen, J.W.G., Erz, D., Seriu, T. and Bartram, C.R. (2000) "Tandem duplication of the FLT3 gene in acute lymphoblastic leukaemia: a marker for the monitoring of minimal residual disease", Leukemia 14, 522-524.
  • Horiike, S., Yokota, S., Nakao, M., Iwai, T., Sasai, Y., Kaneko, H., Taniwaki, M., Kashima, K., Fujii, H., Abe, T. and Misawa, S. (1997) "Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia", Leukemia 11, 1442-1446.
  • Nakano, Y., Kiyoi, H., Miyawaki, S., Asou, N., Ohno, R., Saito, H. and Naoe, T. (1999) "Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene", British Journal of Haematology 104, 659-664.
  • Ishii, E., Zaitsu, M., Ihara, K., Hara, T. and Miyazaki, S. (1999) "High expression but no internal tandem duplication of FLT3 in normal hematopoietic cells", Pediatric Hematologyl Oncology 16, 437 441.
  • Iwai, T., Yokota, S., Nakao, M., Kaneko, H., Nakai, H., Kashima, K. and Misawa, S. (1997) "Internal tandem duplication in the juxtatransmembrane domain of the flt3 is not involved in blastic crisis of chronic myeloid leukaemia", Leukaemia 11, 1922-1933.
  • Abu-Duhier, F.M., Goodeve, A.C., Care, R.S., Peake, I.R., Wilson, G. and Reilly, J.T. (2002) ``FLT3 internal tandem duplication mutations are rare in agnogenic myeloid metaplasia", Blood 100, 364.
  • Kiyoi, H., Towatari, M., Yokota, S., Hamaguchi, M., Ohno, R., Saito, H. and Naoe, T. (1998) "Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of product", Leukemia 12, 1333-1337.
  • Hayakawa, F., Towatari, M., Kiyoi, H., Tanimoto, M., Kitamura, T., Saito, H. and Naoe, T. (2000) "Tandem-duplicated flt3 constitutively activates STATS and MAP kinase and induces autonomous cell growth in IL-3-dependent cell lines", Oncogene 19, 624-631.
  • Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., Akiyarna, H., Sailo, K., Oh, H., Motoji, T., Omoto, E., Saito, H., Ohno, R. and Ueda, R. (1999) "Prognostic implications of FLT3 and N-ras gene mutations in acute myeloid leukaemia", Blood 93, 3074-3080.
  • Rombouts, W.J.C., Blokland, I., Læwenberg, B. and Ploemacher, R.E. (2000) "Biological characteristics and prognosis of adult acute myeloid leukaemia with internal tandem duplications in the FLT3 gene". Leukemia 14, 675-683.
  • Kondo, M., Horibe, K., Takahashi, Y., Matsumoto, K., Fukuda, M., Inaba, J., Kato, K., Kojima, S. and Matsuyama, T. (1999) "Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia", Medical Pediatric Oncology 33, 525-529.
  • Meshinchi, S., Woods, W.G., Stirewall, D.L., Sweetser, D.A., Buckley, J.D., Tjoa, T.K., Bernstein, I.D. and Radich, J.P. (1995) "Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia", Blood 97, 89-94.
  • Kiyoi, H., Naoe, T., Yokota, S., Nakao, M., Minami, S., Kuriyama, K., Takeshita, A., Saito, K., Hasegawa, S., Shimodaira, S., Tamura, J., Shimazaki, C., Matsue, K., Kobayashi, H., Arima, N., Suzuki, R., Morishita, H., Saito, H., Ueda, R. and Ohno, R. (1997) "Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukaemia", Leukemia 11, 1447-1452.
  • Kiyoi, H., Ohno, R., Ueda, R., Sailo, H. and Naoe, T. (2002) "Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain", Oncogene 21, 2555-2563.
  • Mizuki, M., Fenski, R., Halfter, H., Matsumura, I., Schmidt, R., Müller, C., OrU+00Fcning, W., Kratz-Albers, K., Serve, S., Steur, C., BU+00Fcchner, T., Kienast, J., Kanakura, Y., Berdel, W.E. and Serve, H. (2000) "Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways", Blood 96, 3907-3914.
  • Hirota, S., lsozaki, K., Moriyama, Y., Hasimoto, K., Nishida, T., Ishigura, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., Muhammad, T.G., Matsuzawa, Y., Kanakura, Y., Shinomura, Y. and Kitamura, Y. (1998) "Gain-of-function mutations of human gastrointestinal stromal tumors", Science 279, 577-580.
  • Hongyo, T., Li, T., Syaifudin, M., Baskar, R., Ikeda, H., Kanakura, Y., Aozasa, K. and Nomura, T. (2000) "Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan", Cancer Research 60, 2345-2347
  • Boissan, M., Feger, F., Guillossan, J.J. and Arock, M. (2000) "c-kit and c-kit mutations in mastocytosis and other hematological diseases", Journal of Leucocyte Biology 67, 135- 148.
  • GiIIe, H., Kowalski, J., Yu, L., et al., (2000) "A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-I) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration", EMBO Journal 19, 4064-4073.
  • Fenski, R., Flesch, K., Serve, S., Mizuki, M., Oelmann, E., Kratz- Albers, K., Kienast, J., Leo, R., Schwartz, S., Berdel, W.E. and Serve, H. (2000) "Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells", British Journal of Haematology 108, 322-330.
  • Birkenkamp, K.U., Geugien, M., Lemmink, H.H., Kruijer, W. and Vellenga, E. (2001 ) "Regulation of constitutive STAT5 phosphorylalion in acute myeloid leukemia blasts", Leukemia 15, 1923 -1931.
  • Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J.H., Ashman, L.K., Kanayama, Y., Matsuzawa, Y., Kitamura, Y. and Kanakura, Y. (1993) "Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product", Journal of Clinical Investigation 92, 1736 -1744.
  • Tsujimura, T., Furitsu, T., Morimoto, M., Isozaki, K., Nomura, S., Matsuzawa, Y., Kitamura, Y. and Kanakura, Y. (1994) "Ligandindependent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation", Blood 83, 2619-2626.
  • Longley, B.J., Metcalfe, D.D., Tharp, M., Wang, X., Tyrrell, L., Lu, S.Z. Heitjan, D. and Ma, Y. (1999) "Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis", Proceedings of the National Academy of Sciences of the United States of America 96, 1609-1614.
  • Sotlar, K., Marafioti, T., Griesser, H., Theil, J., Aepinus, C., Jaussi, R., Stein, H., Valent, P. and Horny, H.-P. (2000) "Detection of c-kit mutation Asp8l6 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocylic leukaemia", Journal of Clinical Pathology: Molecular Pathology 53, 188-193.
  • [65| Glover, H.R., Baker, DA., Celetti, A. and Dibb, N.J. (1995) "Selection of activating mutations of c-fms in FDC-P1 cells", Oncogene 11, 1347-1356.
  • Abu-Duhier, F.M., Goodeve, A.C., Wilson, G.A., Care, R.S., Peake, I.R. and Reilly, J.T. (2001) "Identification of novel FLT3 Asp835 mutations in adult acute myeloid leukaemia", British Journal of Haematology 113, 983-988
  • Yamamoto, Y., Kiyoi, H., Nakano, Y., Suzuki, R., Kodera, Y., Miyawaki, S., Asou, N., Kuriyama, K., Yagasaki, F., Shimazaki, C., Akiyama, H., Saito, K., Nishimura, M., Motoji, T., Shinagawa, K., Takeshita, A., Saito, H., Ueda, R., Ohno, R. and Naoe, T. (2001) "Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies", Blood 97, 2434-2439.
  • Nomdedeu, J.F., Brunet, S., Colomer, D., Estivill, C., Llorente, J., Carnicer, M.J., Esteve, J. and Sierra, J. (2001) ``D835 mutations are commonly associated with other molecular lesions in adult AML", Blood 98, 579a.
  • Kottaridis, P.D., Gale, R.E., Langabeer, S.E. and Linch, D.C. (2001) "Changes in the pattern of FLT3 mutations between diagnosis and relapse restricts their potential use as markers of minimal residual disease in patients with acute myeloid leukaemia", Blood 98, 7l7a.
  • Sheikhha, M.H., Awan, A., Tobal, K. and Liu Yin, J.A. (2002) "Prognostic significance of FLT ITD and D835 mutations in AML patients", British Journal of Haematology 117(Suppl. I), 5.
  • Morley, G.M., Uden, M., Gullick, W.J. and Dibb, N.J. (1999) "Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation", Oncogene 18, 3076-3084.
  • Johnson, L.N., Noble, M.E. and Owen, D.J. (1996) "Active and inactive protein kinases: structural basis for regulation", Cell 85, 149-158.
  • Gillilland, D.G. (2001) "Hematologic malignancies", Current Opinions in Hematology 8, 189-191.
  • Castilla, L.H., Garrett, L., Adya, N., Orlic. D., Dutra, A., Anderson, S., Owens, J., Eckhaus, M., Bodine, D. and Liu, P.P. (1999) "The fusion gene Cbfß blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia", Nature Genetics 23, 144-146.
  • Kelly, L.M., Liu, Q., Kutok, J.L., Williams, I.R., Boulton, C. and Gilliland, D.G. (2002) "FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model", Blood 99, 310-318.
  • Kelly, L.M., Kutok, J.L., Williams, I.R., Boulton, C.L., Amaral, S.M., Curley, O.P., Ley, T.J. and Gilliland, D.G. (2002) "PML/RARa and FLT3-ITD induce an APL-like disease in a mouse model", Proceedings of the National Academy of Sciences of the United Stairs of America 99, 8283-8288.
  • Carroll, M., Ohno-Jones, S., Tamura, S., Buchdunger, E., Zimmermann, J., Lydon, N., Gilliland, D. and Druker, B. (1997) "CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins", Blood 90, 4947-4952.
  • Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Muller, M., Regenass, U. and Lydon, N.B. (1995) "Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminpyrinidine class", Proceedings of the National Academy of Sciences of the United States of America 92, 2558-2562.
  • Gazit, A., Yaish, P., Gilon, C. and Levitzki, A. (1989) "Tyrphostins I: synthesis and biological activity of protein lyrosine kinase inhibitors", Journal of Medical Chemistry 32, 2344-2352.
  • Gazit, A., App, H., McMahon, G., Chen, J., Levitzki, A. and Bohmer, E. (1996) "Tyrphostins 5. Potent inhibitors of plateletderived growth factor receptor tyrosine Kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins", Journal of Medical Chemistry 39, 2170-2177.
  • Tse, K.-F., Novelli, E., Civin, C.I., Bohmer, F.D. and Small. D. (2001) "Inhibition of FLT3-mediated transformation by the use of a tyrphostin kinase inhibitor", Leukemia 15, 1001-1010.
  • Tse, K.F., Mukherjee, G. and Small, D. (2000) "Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation", Leukemia 14, 1766-1776.
  • Druker, B., Ttamura, S., Buchdunger, E., Ohno, S.,. Segal, G. and Fanning, S. (1996) "Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells", Nature Medicine 2, 561-566.
  • Kovalenko, M., Ronnstrand, L., Heldin, C.-H., Loubtchenkov, M., Gazit, A., Levitzki, A. and Bohmer, F.D. (1997) "Phosphorylalion site-specific inhibition of platelet-derived growth factor B- receptor autophosphorylation by the receptor blocking tyrphostin AG1296", Biochemistry 36, 6260-6269.
  • Zhao, M., Kiyoi, H., Yumamoto, Y., Ilt, M., Towatari, M., Omura, S., Kitamura, T., Ueda, R., Saito, H. and Naoe, T. (2000) ``ln vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor", Leukemia 14, 374-378.
  • Uehara, Y., Murakami, Y., Mizuno, S. and Kawai, S. (1988) "Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A", Virology 164, 294-298.
  • Blagosklonny, M.V. (2002) "Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs", Leukemia 16, 455-462.
  • Levis, M., Allebach, J., Tse, K. F., Zheng, R., Baldwin, B.R., Smith, B.D., Jones-Bolin, S., Ruggeri, B., Dionnem, C. and Small, D. (2002) "A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemic cells in vitro and in vivo", Blood 99, 3885-3891.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.